International
The Morning Science

What science found today

‹
 

Research

Inhibition of NLRP3 maintains microglial architecture and enhances neurological recovery after traumatic brain injury

Cell Reports Medicine · By Sergio Castro-Gomez, Luis José Medina-Centanaro, Juan Ignacio Muñoz-Manco, Ana Vieira-Saecker, Sharumathi Jeyasankar, Ida Kulińska, Tao Li, Felix D. Weiss, Felix Meissner, Stephanie Schwartz, Marion Schneider, Christa E. Müller, Christopher J. Farady, Valentin Stein, Eicke Latz & Michael T. Heneka ·

The Brief

  • NLRP3 drives microglial remodeling, inflammasome assembly and functional deficits after traumatic brain injury, according to Castro-Gomez et al.
  • Genetic deletion or sustained oral inhibition of NLRP3 preserves microglial architecture and limits tissue loss.
  • Both approaches are reported to enhance neurological recovery after traumatic brain injury.

Why it matters

The findings point to NLRP3 as a candidate target for therapies aimed at recovery after traumatic brain injury, and show that microglial structure is linked to functional outcome.

Who’s affected

  • researchers in neuroinflammation and traumatic brain injury
  • drug developers working on NLRP3 inhibitors

Castro-Gomez et al. show that NLRP3 drives microglial remodeling, inflammasome assembly, and functional deficits after traumatic brain injury. Genetic deletion or sustained oral inhibition preserves microglial architecture, limits tissue loss, and improves neurological and…

Timeline

  1. Study published in Cell Reports Medicine

  2. cell.com

    Inhibition of NLRP3 maintains microglial architecture and enhances neurological recovery after traumatic brain injury

How do you feel about this?

0 Comments

    Inhibition of NLRP3 maintains microglial architecture and enhances neurological recovery after traumatic brain injury – The Morning Science